Advancing Science Since 2010
Founded in 2010 and headquartered in Folsom, California, CGT Global is a leading global provider of human primary cells, stem cells, bone marrow, cord blood, peripheral blood, and disease-state products. CGT Global products are used for research and development, clinical trials, and commercial production of cell and gene therapies (allogeneic or autologous) by academic, biotech, diagnostic, pharmaceutical and contract research organizations (CRO’s). The mission of CGT Global is to streamline the cell collection and isolation process, reducing the time it takes for new cures and treatments to reach patient care - giving hope and health back to those afflicted with serious medical conditions. CGT Global is registered with the U.S. Food and Drug Administration (FDA) and has over a dozen global distribution partners and six (6) brick-and mortar locations in the United States, outfitted with GMP certified laboratories. It has been ranked by Inc. 500 as one of the fastest growing companies in the U.S.
Leadership
Cate Spears
Founder & CEO
Mrs. Spears is passionate about business, company culture, and positively impacting the lives of millions by accelerating the cure and prevention of significant medical conditions at life-changing speed. Armed with only $9,000 and a vision, Mrs. Spears founded CGT Global in 2010 and has since opened multiple facilities, cutting-edge laboratories and stem cell collection centers, with a proven record of supporting clinical trials, accelerating R&D and facilitating the commercialization of many products. Mrs. Spears has received multiple highly prestigious awards, including the 2020 "Businesswoman of the Year" award from Sacramento Metro Chamber, and the 2021 "Most Admired CEO" award by Sacramento Business Journal.
Megan Barr
VP of Operations
Megan Barr is an accomplished businesswoman whose acumen has been integral to the growth of CGT Global for over 10 years. She has assisted in the launch of 7 CGT Global collection centers across 6 states. As the VP of operations, she oversees the day-to-day activities throughout the company while maintaining operational efficiency and profitability. She is dedicated to maintaining CGT Global's mission and core values while promoting a thriving company culture. Mrs. Barr has her BS in biology and her MBA in corporate finance with a focus on operational and strategic management.
Julie Squier
VP of Finance
As VP of Finance, Julie Squier leads all financial management, tax, compliance, and IT activities of CGT Global. With over 35 years in accounting and finance, Ms. Squier has developed deep experience in controllership and financial reporting in industries encompassing retail/POS, medical cardiology partnerships, CROs, and GME manufacturing and sales distribution. Some of Ms. Squier’s achievements include integrating 4 acquired companies within 18 months into global operations in SAP, growing Clinipace, Inc. from $2M/year to over $80M annually over a six-year period, and more recently establishing a global treasury function at Blaize across US, EU, and APAC divisions, developing a financial management team covering 24hour centralized accounting/finance functions in a truly global, coordinated effort.